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Chlamydia trachomatis infections cause severe and irrevers-
ible damage that can lead to infertility and blindness in both
males and females. Following infection of epithelial cells,
Chlamydia induces production of reactive oxygen species
(ROS). Unconventionally, Chlamydiae use ROS to their advan-
tage by activating caspase-1, which contributes to chlamydial
growth. NLRX1, a member of the Nod-like receptor family
that translocates to the mitochondria, can augment ROS pro-
duction from the mitochondria following Shigella flexneri in-
fections. However, in general, ROS can also be produced by
membrane-bound NADPH oxidases. Given the importance of
ROS-induced caspase-1 activation in growth of the chlamydial
vacuole, we investigated the sources of ROS production in epi-
thelial cells following infection with C. trachomatis. In this
study, we provide evidence that basal levels of ROS are gener-
ated during chlamydial infection by NADPH oxidase, but ROS
levels, regardless of their source, are enhanced by an NLRX1-
dependent mechanism. Significantly, the presence of NLRX1 is
required for optimal chlamydial growth.
During electron transfer reactions, eukaryotic cells generate
highly reactive O2 metabolites collectively known as reactive
oxygen species (ROS).2 Given their high cellular toxicity, cells
have developed mechanisms to maintain the levels of ROS in
a homeostatic state and utilize them in cellular functions, in-
cluding signaling pathways, gene expression regulation, and
host defense mechanisms (1–3). Intracellular ROS generation
is mediated by several enzymatic reactions, but the bulk of
ROS is generated from two sources: the mitochondrial elec-
tron transport chain complex and membrane-bound NADPH
oxidase (NOX and DUOX) (4).
During oxidative phosphorylation in the mitochondria, O2
is reduced to O2. , which in turn is converted by superoxide
dismutase into H2O2, which then diffuses across the mito-
chondrial membrane to the cytoplasm (4). Notably, NLRX1, a
member of the intracellular Nod-like receptor (NLR) family
that is localized in mitochondria, enhances ROS production
induced by poly(IC), TNF, and Shigella flexneri infection
(5). Although there is evidence that NLRX1 is the only NLR
member that is found in mitochondria, its exact dynamic lo-
calization remains to be determined. Results from one study
suggested that NLRX1 localizes to the outer mitochondrial
membrane (6), but subsequent characterization suggests that
NLRX1 is transported to the mitochondrial matrix, where it
interacts with UQCRC2, a matrix-facing protein of respira-
tory chain complex III (bc1 complex). The bc1 complex is
known to play an essential role in ROS generation from the
mitochondria (5, 7).
Chlamydia trachomatis is the first cause of bacterial sexu-
ally transmitted disease in the United States, and the inci-
dence of infection has been increasing for the past 20 years
(8–10). The bacteria infect their preferred target cells, cervi-
cal epithelial cells, through entry vacuoles that avoid fusion
with host cell lysosomes and then grow by subverting cell sig-
naling pathways in the host cells and acquiring lipids from the
Golgi apparatus (11–14). Host cells often produce ROS in
response to bacterial infections as a defense mechanism to
impair metabolism and growth of intracellular bacteria by
inflicting damage to the pathogen’s lipids, proteins, and nu-
cleic acids (15). However, in the case of chlamydial infection
of epithelial cells, the intracellular Chlamydiae stimulate the
host cell to generate moderate amounts of ROS. These low
levels of ROS lead to NLRP3 inflammasome-mediated
caspase-1 activation, which contributes to chlamydial infec-
tion (16). Although the basis for caspase-1 stimulation of
chlamydial infection is not known, caspase-1 has many non-
inflammatory substrates and can stimulate metabolism of
host cell lipids (17, 18). Therefore, we investigated the sources
of intracellular ROS generation in epithelial cells during infec-
tion with C. trachomatis.
Here, we show that both NOX/DUOX and NLRX1 contrib-
ute to C. trachomatis-dependent ROS production. Inhibition
of NOX/DUOX resulted not only in abrogation of ROS pro-
duction but also lower chlamydial growth. Specifically, deple-
tion of NOX/DUOX superfamily members NOX4, DUOX1,
and DUOX2 resulted in lower ROS production during infec-
tion. Similarly, silencing NLRX1 expression led to a signifi-
cant decrease in ROS levels during chlamydial infection,
1 To whom correspondence should be addressed: School of Natural Sci-
ences, University of California, 5200 North Lake Rd., Merced, CA 95343.
E-mail: david.ojcius@gmail.com.
2 The abbreviations used are: ROS, reactive oxygen species; NOX, NADPH
oxidase; DUOX, dual oxidase; NLR, Nod-like receptor; MEF, mouse embry-
onic fibroblast; DPI, diphenyliodonium chloride; m.o.i., multiplicity of
infection; DCF, 5(6)-chloromethyl-2,7-dichlorodihydrofluorescein diac-
etate acetyl ester.
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whereas overexpression of NLRX1 augmented Chlamydia-
induced ROS production. NLRX1 enhanced ROS levels even
when cells were treated with extracellular H2O2, suggesting
that mitochondrial NLRX1 can enhance ROS levels regardless
of their source. Our data indicate that ROS, usually produced
in large quantities by immune cells to limit the growth of in-
vading pathogens, is utilized by Chlamydia to promote its
own growth and is generated from two sites: membrane-
bound NOX and mitochondrial NLRX1.
EXPERIMENTAL PROCEDURES
Cells, Bacteria, and Chemical Reagents—Human cervical
epithelial cells (HeLa 229 cells) were obtained from American
Type Culture Collection, and Nlrx1/mouse embryonic
fibroblast (MEF) cells were derived from Nlrx1/ animals
(produced together with genOway). The LGV/L2 strain of
C. trachomatis was grown as described previously (19). HeLa
cells were cultured in a humidified incubator at 37 °C with 5%
CO2 in DMEM/F-12 (Invitrogen) supplemented with 10%
FBS (Invitrogen) and 10 g/ml gentamycin (Omega Scientific,
Tarzana, CA). MEF cells were cultured in a humidified incu-
bator at 37 °C with 5% CO2 in RPMI 1640 medium (Invitro-
gen) supplemented with 10% heat-inactivated FBS (Invitro-
gen), 1% nonessential amino acids (Invitrogen), and 10 g/ml
gentamycin. C. trachomatis cells were grown in infected HeLa
cell monolayer cultures to determine the number of bacterial
inclusion-forming units as described previously (20). Diphe-
nyliodonium chloride (DPI) was purchased from Alexis Bio-
chemicals. Lipofectamine 2000 was purchased from Invitro-
gen. Hydrogen peroxide and the monoclonal antibody against
tubulin were purchased from Sigma. The anti-NLRX1 poly-
clonal antibody was made as described previously (7).
Generation of siRNA against Human NLRX1—The se-
quences (sense strand) of the siRNA targeting NLRX1 and the
scrambled siRNA were as follows: 5-GAGGAGGACTACTA-
CAACGAT-3 (NLRX1) and 5-GTGCAGGAGTAGGGCA-
TTTAA-3 (scrambled). The pLKO.1 lentiviral knockdown
system (Addgene, Cambridge, MA) was used to generate len-
tiviral shRNA particles, and oligonucleotides containing the
siRNA sequences were designed according to the pLKO.1
protocol of Addgene. Annealed oligonucleotides were ligated
with digested pLKO.1 plasmid (EcoRI/AgeI) for 4 h at
16 °C, and positive clones were identified by restriction
enzyme digestion (EcoRI/NcoI). shRNA constructs were
fully sequenced with the pLKO.1 sequencing primer
(5-AAGGCTGTTAGAGAGATAATTGGA-3).
Lentiviral Packaging—Packaging and purification of the
lentivirus were performed according to standard procedures.
HEK293T cells (1.6 106 cells) were seeded in a 10-cm cul-
ture dish in DMEM supplemented with 10% FBS without an-
tibiotics. The following day, cells were cotransfected with the
lentiviral vector (1 g) and the lentiviral packaging/envelope
vectors psPAX2 (750 ng) and pMD2.G (250 ng). Viruses were
collected from the culture supernatant 24–48 h post-trans-
fection and spun at 1250 rpm for 5 min, and the medium was
passed through a 0.45-m filter.
Lentiviral Transduction in HeLa cells—Cells were seeded in
6-well plates and then incubated with lentivirus for at least 3
days in the presence of Polybrene (10 g/ml). Cells that were
successfully transfected were selected by adding a fresh me-
dium that contained 2 g/ml puromycin (Sigma) and further
incubated for 24 h. Knockdown of NLRX1 protein expression
was confirmed by Western blotting using rabbit anti-NLRX1
polyclonal antibody designed against CQLVAQRYTPLKEV
(amino acids 214–227) of NLRX1 (Cedarlane Laboratories,
Hornby, Canada).
Transient Transfection of HeLa Cells—The NLRX1-FLAG
overexpression construct described previously (5) was tran-
siently transfected into HeLa cells using Lipofectamine 2000
reagent according to the manufacturer’s instructions. Briefly,
cells were plated 1 day before transfection so that cells would
be 95% confluent at the time of transfection. Lipofectamine
2000 mixture was prepared by diluting the appropriate
amount in serum-free medium (4 l of Lipofectamine/1.6 g
of DNA) and incubating for 5 min at room temperature. A
plasmid mixture was then prepared by diluting plasmid DNA
in serum-free medium. The DNA and Lipofectamine mix-
tures were combined gently and incubated for 20 min at room
temperature. DNA/Lipofectamine complexes were then
added dropwise to each well containing cells and serum-free
medium, and cells were incubated at 37 °C with 5% CO2 for
6 h, detached using TrypLETM Express (Invitrogen), and
plated to obtain 50% confluency after 18 h.
NADPH Oxidase Components—NOX1, NOX4, DUOX1,
and DUOX2 were each depleted with three different siRNA
constructs as described previously (21). The sequences of the
NOX1 siRNA constructs were 5-AAAACAUUCAGC-
CCUAACCaa-3, 5-AAUGUUGACCCAAGGAUUUtt-3,
and 5-UGUGAUCCAAUUGCUUUCUca-3. The sequences
of the NOX4 siRNA constructs were 5-GUGAUACUCUG-
GCCCUUGGtt-3, 5-UUAUCCAACAAUCUCCUGGtt-3,
and 5-UGGUUAUACAGCAAGAAGGtt-3. The sequences
of the DUOX1 siRNA constructs were 5-AUCUUCAAC-
CAACACAUGGTC-3, 5-UACACGCCAUCUG-
CAUAGCtg-3, and 5-GUACCACCCAUCAAAUCGCtg-3.
The sequences of the DUOX2 siRNA constructs were 5-
CAUUAGACGGGACUUAUCCtg-3, 5-ACCUUCCG-
GAAAUGACAGCTG-3, and 5-UUCAACCACUAUGUU-
GUCCtc-3. Control siRNA (MISSION siRNA universal
negative control, Sigma) was used as a control for the knock-
down procedure. Cells were transfected with siRNA con-
structs and Lipofectamine 2000 reagent following the manu-
facturer’s instructions.
Cell Culture, Infection, and Treatments—HeLa cells grow-
ing at 50% confluency on tissue culture plates (Costar, Corn-
ing, NY) were infected with the LGV/L2 strain of C. tracho-
matis at a multiplicity of infection (m.o.i.) of 3.0 unless
specified otherwise and incubated for the indicated times in
an incubator at 37 °C with 5% CO2. MEF cells growing at 80%
confluency on tissue culture plates were infected with the
LGV/L2 strain of C. trachomatis at an m.o.i. of 3.0 and incu-
bated for 24 h in an incubator at 37 °C with 5% CO2. Treat-
ment with inhibitors or other reagents was performed at the
indicated times and concentrations.
Measurement of ROS Production—HeLa cells were labeled
with the cell-permeant ROS indicator 5(6)-chloromethyl-
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2,7-dichlorodihydrofluorescein diacetate acetyl ester (DCF;
Invitrogen) following the manufacturer’s instructions. Briefly,
cells were plated in phenol red-free DMEM containing 10%
FBS and then infected and/or treated for the indicated times.
Cells were detached using TrypLETM Express, loaded with 2.5
M DCF in PBS for 15 min at 37 °C, washed with PBS, resus-
pended in growth medium, and finally analyzed by flow cy-
tometry with a Guava EasyCyte system with a 15-milliwatt
argon ion laser at 488 nm. Fluorescence was measured on the
FL1 (green) channel, gating only on live cells.
FLICA Staining—During the last hour of incubation, cells
were labeled using a carboxyfluorescein-YVAD-fluoromethyl
ketone caspase-1 FLICATM kit (ImmunoChemistry Technolo-
gies, Bloomington, IN), which binds to activated caspase-1.
Flow cytometric analysis was performed as described previ-
ously (16). Briefly, cells were detached using TrypLETM Ex-
press and then incubated with FLICA for 1 h, followed by two
washes and analysis using the Guava EasyCyte system.
Immunocytochemical Staining and FluorescenceMicroscopy—
For MitoTracker and indirect anti-FLAG immunocytochemi-
cal staining, cells were grown on coverslips and then trans-
fected with the NLRX1-FLAG construct as described above.
Cells were loaded with 500 nM MitoTrackerOrange (Molec-
ular Probes) and incubated for 45 min at 37 °C, followed by
fixation with 4% paraformaldehyde (Sigma) for 15 min at
room temperature (22). Fixed cells were probed with anti-
FLAG monoclonal antibody M2 (1:1000; Sigma) for 2 h at
37 °C, followed by incubation with FITC-conjugated anti-
mouse IgG antibody (Sigma) for 45 min at 37 °C. During the
last 5 min of incubation, Hoechst stain (Sigma) was added,
and cells were viewed on a wide-field fluorescence micro-
scope (Leica, Deerfield, IL). Hoechst, NLRX1-FLAG, and Mi-
toTracker were viewed with blue, green, and red filters, re-
spectively. For direct anti-FLAG immunocytochemical
staining, cells were fixed with a freshly prepared mixture of
methanol/acetone (1:1) and incubated with Cy3TM-conju-
gated anti-FLAG monoclonal antibody M2 (Sigma) at 1
mg/ml for 1 h. Anti-chlamydial antibody (Argene, Massape-
qua, NY) and Hoechst stain were added during the last 15 and
5 min of incubation, respectively. Cells were mounted on a
FIGURE 1.NLRX1 translocation to mitochondria in infected and uninfected cells. HeLa cells growing on coverslips were transfected using Lipo-
fectamine 2000 reagent with the NLRX1-FLAG construct and infected or mock-infected with the LGV/L2 strain of C. trachomatis at an m.o.i. of 3 for 24 h.
A, uninfected cells were fixed and stained with Hoechst stain (blue), MitoTracker (red), and anti-FLAG antibody (green). B, infected cells were stained with
Cy3-conjugated anti-FLAG antibody (red) and anti-chlamydial antibody (green). In both cases, the cells were visualized on a fluorescence microscope.WT,
wild-type (Lipofectamine only).
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glass slide, sealed with nail polish, and viewed with a Leica
wide-field fluorescence microscope. Hoechst, Chlamydiae,
and NLRX1-FLAG were viewed with the blue, green, and red
filters, respectively.
RNA Isolation and Real-time PCR—mRNA was isolated
from cells after the indicated treatments or infections using
the Qiagen RNeasy kit following the manufacturer’s instruc-
tions, and total RNA was converted into cDNA by standard
reverse transcription with the TaqMan reverse transcriptase
kit (Applied Biosystems, Foster City, CA). For measurements
of chlamydial 16 S rRNA, total mRNA was isolated using
TRIzol reagent (Invitrogen) following the manufacturer’s in-
structions. Quantitative PCR was performed with the cDNA
preparation (1:50) in the Mx3000P system (Stratagene, La
Jolla, CA) in a 25-l final volume with Brilliant QPCR Master
Mix (Stratagene). The primers for human GAPDH were 5-
CTTCTCTGATGAGGCCCAAG-3 (forward) and 5-
GCAGCAAACTGGAAAGGAAG-3 (reverse). The primers
for human NLRX1 were 5-GTGCCCGGAAGCT-
GGGCTTG-3 (forward) and 5-CCGGGCACCACCT-
TCAGCAG-3 (reverse). The primers for human NOX1 were
5-CACCCCAAGTCTGTAGTGGGAG-3 (forward) and
5-CCAGACTGGAATATCGGTGAC-3 (reverse). The
primers for human NOX4 were 5-GGGCTTCCACT-
CAGTCTTTG-3 (forward) and 5-GTTGAGGGCATTCAC-
CAGAT-3 (reverse). The primers for human DUOX1 were
5-TTCACGCAGCTCTGTGTCAA-3 (forward) and 5-
AGGGACAGATCATATCCTGGCT-3 (reverse). The prim-
ers for human DUOX2 were 5-ACGCAGCTCTGTGT-
CAAAGGT-3 (forward) and 5-TGATGAACGAGACTCG-
ACAGC-3 (reverse). The primers for C. trachomatis 16 S
rRNA were 5-CCCGAGTCGGCATCTAATAC-3 (forward)
and 5-CTACGCATTTCACCGCTACA-3 (reverse). The
primers for murine IFN- were described previously (23).
Real-time PCR included initial denaturation at 95 °C for 10
min, followed by 40 cycles at 95 °C for 30 s, 55 °C for 1 min,
and 72 °C for 1 min and one cycle at 95 °C for 1 min, 55 °C for
30 s, and 95 °C for 30 s. For human genes, the CT values were
normalized to the housekeeping gene GAPDH. For chlamy-
dial 16 S RNA measurements, equal amounts of cDNA were
loaded in all samples.
Statistical and Flow Cytometric Analyses—Statistical analy-
sis was performed using GraphPad InStat software by Stu-
dent’s t test and was considered significant at p 0.05. Flow
cytometry data were analyzed using FlowJo software (Tree
Star Inc., Ashland, OR).
RESULTS ANDDISCUSSION
NLRX1 Overexpression Augments C. trachomatis-induced
ROS Production—A recent study demonstrated that NLRX1,
the only NLR family member that translocates to the mito-
chondria, enhances ROS production induced by cytokines
and S. flexneri infection (5). To test whether NLRX1 may play
a role in Chlamydia-induced ROS production, we overex-
FIGURE 2.NLRX1overexpression augmentsC. trachomatis-inducedROSproduction.HeLa cells were transfected using Lipofectamine 2000 reagent (Lipo)
with empty vector (pcDNA3.1) or the NLRX1-FLAG construct and infected ormock-infectedwith the LGV/L2 strain of C. trachomatis at anm.o.i. of 3. A, cells were
infected ormock-infected for 24 h. ROS productionwasmeasuredwith the ROS-sensitive dyeDCF and analyzed by flow cytometry. Non-fluorescent cells were
gated in the first log decade, and the fluorescence intensity was proportional to the level of ROS production. Flow cytometry data of infected cells are presented as
a histogram (left panel), and the amount of ROS production in infected cells relative to uninfected controls (Ctrl) is presented as a bar chart (right panel). Data are
fromone representative experiment. B, cells were infected ormock-infected for 0, 16, 20, or 24 h, and ROS productionwasmeasured by flow cytometry under the
same conditions as described for A. Relative ROS levels were quantified as themeanDCF fluorescence, and the valuesmeasured in uninfectedwild-type cells were
subtracted from the other conditions. Error bars represent S.D. (n 3). *, p 0.05 comparedwithwild-type infected cells (Lipofectamine only).
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pressed NLRX1 using the NLRX1-FLAG construct in HeLa
cells. First, we confirmed by immunofluorescence microscopy
that NLRX1 is overexpressed in HeLa cells and that it translo-
cates to mitochondria (Fig. 1A). We also verified that C. tra-
chomatis infection of NLRX1-overexpressing epithelial cells
does not affect the distribution of NLRX1 (Fig. 1B).
We then measured ROS production in C. trachomatis-in-
fected HeLa cells treated with Lipofectamine alone or trans-
fected with empty vector or with NLRX1-FLAG. We demon-
strated that NLRX1-overexpressing HeLa cells produced
higher levels of ROS in response to C. trachomatis infection
than those treated with Lipofectamine (control) or transfected
with empty vector (Fig. 2A). Consistent with the previous ob-
servation that ROS production during C. trachomatis infec-
tion increases 20 h post-infection and continues to increase at
24 h post-infection (16), NLRX1-dependent enhancement of
ROS production was observed especially at 20 and 24 h post-
infection (Fig. 2B). These data imply that NLRX1 may con-
tribute to Chlamydia-induced ROS production in epithelial
cells.
NLRX1 Enhances ROS Generation during Chlamydial
Infection—The NLRX1 overexpression system suggested a
potential role for NLRX1 in C. trachomatis-induced ROS pro-
duction. We further investigated this possibility by reducing
expression of endogenous NLRX1 in epithelial cells using
shRNA that specifically targets NLRX1 mRNA. Expression of
NLRX1 mRNA was significantly reduced in comparison with
cells transfected with non-target shRNA as measured by real-
time PCR (Fig. 3C), and depletion of NLRX1 protein was con-
firmed by Western blot analysis (Fig. 3C, inset). Depletion of
NLRX1 caused a reduction of50% in the production of ROS
after 24 h of C. trachomatis infection compared with HeLa
cells that were transfected with scrambled shRNA (control)
(Fig. 3, A and B). These results were confirmed using MEFs
from Nlrx1 knock-out mice. When Nlrx1 knock-out MEFs
were infected with C. trachomatis for 24 h, there was signifi-
cantly less ROS produced than when wild-type MEFs were
infected (Fig. 4, A and B). Collectively, these data indicate that
NLRX1 contributes to generation of ROS during infection
with C. trachomatis.
FIGURE 3.NLRX1 contributes to C. trachomatis-induced ROS production in epithelial cells. HeLa cells were transfected using Lipofectamine 2000 rea-
gent with scrambled (shScr Ctrl) and NLRX1 (shNLRX1) shRNA constructs and infected or mock-infected with C. trachomatis at an m.o.i. of 3 for 24 h. A, ROS
production was measured with DCF and analyzed by flow cytometry. Non-fluorescent cells were gated in the first log decade, and the fluorescence inten-
sity was proportional to the level of ROS production. B, the bar chart represents ROS production in C. trachomatis-infected HeLa cells analyzed by flow cy-
tometry under the conditions described for A. C, mRNA expression of NLRX1 was quantified by real-time PCR and compared with the scrambled shRNA (sh
Scramble). Inset, HeLa cells were transduced for 72 h with lentiviruses expressing either NLRX1 shRNA or scrambled shRNA (Scr shRNA), and NLRX1 expres-
sion was determined by Western blotting using anti-NLRX1 antibody. Protein loading was controlled using an anti-tubulin antibody. The asterisk indicates a
nonspecific band. Error bars represent S.D. (n 3). *, p 0.05; ***, p 0.001 compared with scrambled shRNA-infected cells.
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NLRX1-mediated ROS Production Is Required for Optimal
Chlamydial Growth—To determine whether NLRX1-medi-
ated ROS production during chlamydial infection plays a role
in development of the chlamydial inclusion, we depleted
NLRX1 in epithelial cells with NLRX1 shRNA and measured
chlamydial 16 S rRNA by real-time PCR in cells infected with
C. trachomatis for 24 h. In fact, C. trachomatis growth was
significantly lower in epithelial cells that had a reduced ex-
pression of NLRX1 (Fig. 5A, sh NLRX1) compared with wild-
type cells or cells transfected with control reagents (Fig. 5A, sh
Scramble). Similarly, the complete absence of Nlrx1 expres-
sion in Nlrx1 knock-out MEFs led to a significantly reduced
level of chlamydial growth, as shown by the lower chlamydial
16 S rRNA obtained from these cells compared with wild-type
MEFs (Fig. 5B).
NLRX1 has been reported to inhibit IFN- production by
interacting with the signaling adaptor MAVS (mitochondrial
antiviral signaling) (6). Infection by Chlamydophila pneu-
moniae and Chlamydia muridarum also leads to IFN- pro-
duction. However, the production during C. pneumoniae in-
fection requires MAVS, whereas C. muridarum infection
induces IFN- in the absence of MAVS (23, 24). We therefore
considered the possibility that some of the decrease in C. tra-
chomatis infection in Nlrx1 knock-out MEFs may be due to
enhanced IFN- production, which could indirectly inhibit
chlamydial infection. However, on the contrary, we found that
FIGURE 4.NLRX1 contributes to C. trachomatis-induced ROS production in murine fibroblasts.Wild-type (WT) or Nlrx1 knock-out (KO) MEFs were in-
fected or mock-infected with C. trachomatis at an m.o.i. of 3 for 24 h. A, ROS production was measured with DCF and analyzed by flow cytometry. Non-fluo-
rescent cells were gated in the first log decade, and the fluorescence intensity was proportional to the level of ROS production. B, the bar chart represents
ROS production in C. trachomatis-infected MEF cells analyzed by flow cytometry under the conditions described for A. Error bars represent S.D. (n 3). **,
p 0.01 compared with wild-type infected cells. Ctrl, control.
FIGURE 5. NLRX1 expression enhances chlamydial growth. A, HeLa cells were transfected using Lipofectamine 2000 reagent with scrambled (sh Scram-
ble) and NLRX1 (sh NLRX1) shRNA constructs and infected with C. trachomatis at an m.o.i. of 3 for 24 h. B and C, wild-type (WT) or Nlrx1 knock-out (KO) MEFs
were infected with C. trachomatis at an m.o.i. of 3 for 24 h. Infection and IFN- levels were quantified by real-time PCR. Total RNA was harvested for quantifi-
cation of chlamydial 16 S rRNA production (A and B) or IFN- expression (C) using real-time PCR as described under “Experimental Procedures”. Error bars
represent S.D. of at least three separate experiments. **, p 0.01 compared with infected cells treated with Lipofectamine only (A,WT) or wild-type cells (B
and C).
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Nlrx1 deficiency leads to a decrease in IFN- production (Fig.
5C). These results suggest that lower chlamydial infection in
Nlrx1-deficient cells therefore leads to lower IFN- produc-
tion. In addition, our results are consistent with the possibility
that IFN- production during C. trachomatis infection is in-
dependent of MAVS, as in the case of C. muridarum
infection.
NADPH Oxidase Is Essential for ROS Production and
Chlamydial Growth—To investigate whether NOX is in-
volved in Chlamydia-induced ROS production in epithelial
cells, we infected HeLa cells with C. trachomatis for 24 h and
treated them 9 h post-infection with DPI, a potent and com-
monly used inhibitor of NOX or the NADPH oxidase family
member DUOX. Inhibition of these enzymes by DPI caused a
significant dose-dependent reduction in Chlamydia-induced
ROS production (Fig. 6A). Importantly, we used significantly
lower DPI concentrations (1–100 nM) in our study than the
concentrations (10 M) often used for NOX inhibition (25–
27). As we recently showed that infection-dependent ROS
production results in caspase-1 activation in epithelial cells
(16), we verified that the same DPI concentrations also inhib-
ited caspase-1 activation during chlamydial infection using
FLICACasp1, a cell-permeable fluorescent reagent that can
specifically bind to the active form of caspase-1 (Fig. 6B).
We then tested whether the attenuation of ROS production
caused by inhibition of NOX or DUOX can affect chlamydial
growth by measuring the amount of chlamydial 16 S rRNA
produced by infected cells. Indeed, treatment of C. trachoma-
tis-infected HeLa cells with 100 nM DPI almost completely
abrogated 16 S rRNA production by 24 h post-infection in a
dose-dependent manner compared with controls (Fig. 6C).
These results suggest that NOX and/or DUOX is a key en-
zyme in ROS production during chlamydial infection, which
in turn is essential for caspase-1-dependent chlamydial
growth.
To confirm the results with the inhibitor DPI, we also de-
pleted, by RNA interference, the NOX/DUOX superfamily
members that are expressed in HeLa cells (21, 28, 29). Thus,
HeLa cells were transfected with siRNA constructs for NOX1,
NOX4, DUOX1, and DUOX2 before infection with C. tracho-
matis. Depletion of DUOX1 and DUOX2 reduced ROS pro-
duction significantly, whereas depletion of NOX4 had a
smaller effect (Fig. 6D). Depletion of NOX1 had a negligible
effect (data not shown), which may also be due to the previ-
FIGURE 6. Chlamydia-induced ROS production requires NADPH oxidase in epithelial cells. A and B, HeLa cells were infected or mock-infected with
C. trachomatis at an m.o.i. of 3 for 24 h in the presence of 0, 1, 10, 50, or 100 nM DPI (NOX and DUOX inhibitor) during the last 9 h of infection. A, ROS produc-
tion was quantified by staining cells with DCF and measuring by flow cytometry. B, caspase-1 activation was quantified using fluorescent FLICACasp1 rea-
gent and measuring by flow cytometry. C, HeLa cells were infected or mock-infected with C. trachomatis at an m.o.i. of 3 for 24 h and treated with 0, 5, 10,
50, or 100 nM DPI during the last 9 h of infection. Total RNA was harvested for quantification of chlamydial 16 S rRNA production using real-time PCR as de-
scribed under “Experimental Procedures.” D, HeLa cells were transfected with control (si Ctrl), NOX4 (si Nox4), DUOX1 (si Duox1), and DUOX2 (si Duox2) siRNA
constructs and infected or mock-infected with C. trachomatis at an m.o.i. of 3 for 24 h. ROS production was quantified by staining the cells with DCF and
measuring ROS by flow cytometry. Error bars represent S.D. of at least three separate experiments. **, p 0.01; ***, p 0.001 compared with infected un-
treated cells (A–C) or with uninfected cells treated with control siRNA (D).
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ous observation that NOX1 is expressed in HeLa cells at
much lower levels than NOX4 (28).
NLRX1 Can Amplify ROS Production due to Treatment
with Exogenous Hydrogen Peroxide—Although NLRX1 is par-
tially required for Chlamydia-induced ROS production, inhi-
bition of NOX and/or DUOX by DPI led to nearly complete
abrogation of ROS production following chlamydial infection.
This suggests that, following infection, ROS is first generated
by NOX/DUOX, and the ROS then diffuses into the mito-
chondria, resulting in further production of ROS in an
NLRX1-dependent fashion. To test this hypothesis, we
treated wild-type and NLRX1-depleted HeLa cells with differ-
ent concentrations of exogenous H2O2 for 45 min and mea-
sured its induced ROS production. In fact, the addition of 75
or 100 M H2O2 led to significantly lower ROS levels in
NLRX1-depleted HeLa cells compared with control cells
treated with the same concentrations of H2O2 (Fig. 7). Higher
concentrations of H2O2 caused a saturated response inde-
pendent of NLRX1. These results suggest that moderate levels
of exogenous H2O2 can indeed stimulate mitochondrial
NLRX1 to augment ROS levels in epithelial cells.
Conclusions—We have shown previously that chlamydial
infection of epithelial cells leads to K efflux in the host cells,
which results in ROS production and NLRP3-dependent
caspase-1 activation (16). In turn, chlamydial growth requires
caspase-1 activation.
ROS is generated mainly by NOX on the plasma membrane
and mitochondria. Other studies have reported ROS produc-
tion during chlamydial infection (30, 31), but they did not
identify the source of host cell-derived ROS production. In
this study, we have demonstrated that ROS production during
C. trachomatis infection of epithelial cells is due primarily to
two sources: NOX enzymes and NLRX1. Inhibition of NOX
almost completely abrogated Chlamydia-induced ROS pro-
FIGURE 7. Exogenous ROS leads to further ROS generation in an NLRX1-
dependent manner. HeLa cells were transfected using Lipofectamine 2000
reagent with scrambled (sh Scramble) and NLRX1 (sh NLRX1) shRNA con-
structs, and exogenous hydrogen peroxide (H2O2) was added at concentra-
tions varying from 50 to 400 M for 45 min. ROS production was measured
with DCF and analyzed by flow cytometry. Non-fluorescent cells were gated
in the first log decade, and the fluorescence intensity was proportional to
the level of ROS production. Error bars represent S.D. of at least three sepa-
rate experiments. *, p 0.05, NLRX1 shRNA-treated cells compared with
scrambled shRNA-treated cells.
FIGURE 8.NADPH oxidase and NLRX1-mediatedmitochondrial production of ROS in response to C. trachomatis infection. Following infection,
Chlamydiae inject virulence factors via the type 3 secretion (T3S) apparatus into the host cell cytosol, causing efflux of potassium, activation of NADPH oxi-
dase, and production of ROS. ROS generated during chlamydial infection comes from two sources: NOX/DUOX and NLRX1. ROS then leads to NLRP3-medi-
ated caspase-1 (Casp1) activation, which is required for optimal chlamydial growth. ASC, apoptosis-associated speck-like protein.
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duction and the ability of Chlamydiae to maintain reproduc-
tive infection, whereas the NLR family member NLRX1 en-
hanced ROS production and was required for optimal
chlamydial growth. Thus, NLRX1 overexpression in epi-
thelial cells augments ROS production induced by chlamy-
dial infection, whereas NLRX1 depletion by shRNA leads
to a significant reduction in the amount of ROS produced.
Using fibroblasts from Nlrx1-deficient mice, we confirmed
the role of NLRX1 in the generation of ROS during
chlamydial infection because Nlrx1-deficient cells exhib-
ited a much lower level of ROS production compared with
wild-type cells.
During infection, Chlamydiae inject virulence factors via
the type 3 secretion apparatus into the host cell cytosol, caus-
ing efflux of K and production of ROS. Because the presence
of endogenous NLRX1 did not overcome the inhibitory ef-
fects on ROS production of a NOX inhibitor, we propose that
intracellular Chlamydiae first induce NOX-dependent pro-
duction of ROS, which diffuse to the mitochondrial matrix
and interact with NLRX1, thereby stimulating a further round
of ROS production (Fig. 8). Moreover, we and others have
shown that chlamydial infection can also stimulate the NLR
family members Nod1 and Nod2 (32–35), and Nod2 has re-
cently been found to interact with DUOX2, resulting in
Nod2-dependent ROS production (21). Regardless of the
source of the ROS (NOX or DUOX2), the ROS then leads to
NLRP3-mediated caspase-1 activation, which is required for
optimal chlamydial growth.
Chlamydia is an astute pathogen because it can evade the
immune system in many ways and modulate host cell signal-
ing pathways in a well orchestrated and timely manner (14,
36–40). Paradoxically, C. trachomatis also turns one of the
host cell’s own defense mechanisms, ROS production, to its
own advantage, providing one further example of this patho-
gen’s ability to subvert the host immune response.
REFERENCES
1. Woo, H. A., Yim, S. H., Shin, D. H., Kang, D., Yu, D. Y., and Rhee, S. G.
(2010) Cell 140, 517–528
2. Hamanaka, R. B., and Chandel, N. S. (2009) Curr. Opin. Cell Biol. 21,
894–899
3. Landriscina, M., Maddalena, F., Laudiero, G., and Esposito, F. (2009)
Antioxid. Redox Signal. 11, 2701–2716
4. Novo, E., and Parola, M. (2008) Fibrogenesis Tissue Repair 1, 5
5. Tattoli, I., Carneiro, L. A., Je´hanno, M., Magalhaes, J. G., Shu, Y., Phil-
pott, D. J., Arnoult, D., and Girardin, S. E. (2008) EMBO Rep. 9, 293–300
6. Moore, C. B., Bergstralh, D. T., Duncan, J. A., Lei, Y., Morrison, T. E.,
Zimmermann, A. G., Accavitti-Loper, M. A., Madden, V. J., Sun, L., Ye,
Z., Lich, J. D., Heise, M. T., Chen, Z., and Ting, J. P. (2008) Nature 451,
573–577
7. Arnoult, D., Soares, F., Tattoli, I., Castanier, C., Philpott, D. J., and Girar-
din, S. E. (2009) J. Cell Sci. 122, 3161–3168
8. Gerbase, A. C., Rowley, J. T., and Mertens, T. E. (1998) Lancet 351, 2–4
9. Miller, W. C., Ford, C. A., Morris, M., Handcock, M. S., Schmitz, J. L.,
Hobbs, M. M., Cohen, M. S., Harris, K. M., and Udry, J. R. (2004) JAMA
291, 2229–2236
10. Belland, R., Ojcius, D. M., and Byrne, G. I. (2004) Nat. Rev. Microbiol. 2,
530–531
11. Wyrick, P. B. (2000) Cell. Microbiol. 2, 275–282
12. Bavoil, P. M., Hsia, R., and Ojcius, D. M. (2000)Microbiology 146,
2723–2731
13. Rockey, D. D., Scidmore, M. A., Bannantine, J. P., and Brown, W. J.
(2002)Microbes Infect. 4, 333–340
14. Carabeo, R. A., Mead, D. J., and Hackstadt, T. (2003) Proc. Natl. Acad.
Sci. U.S.A. 100, 6771–6776
15. Flannagan, R. S., Cosío, G., and Grinstein, S. (2009) Nat. Rev. Microbiol.
7, 355–366
16. Abdul-Sater, A. A., Koo, E., Ha¨cker, G., and Ojcius, D. M. (2009) J. Biol.
Chem. 284, 26789–26796
17. Shao, W., Yeretssian, G., Doiron, K., Hussain, S. N., and Saleh, M. (2007)
J. Biol. Chem. 282, 36321–36329
18. Gurcel, L., Abrami, L., Girardin, S., Tschopp, J., and van der Goot, F. G.
(2006) Cell 126, 1135–1145
19. Ojcius, D. M., Degani, H., Mispelter, J., and Dautry-Varsat, A. (1998)
J. Biol. Chem. 273, 7052–7058
20. Perfettini, J. L., Ojcius, D. M., Andrews, C. W., Jr., Korsmeyer, S. J.,
Rank, R. G., and Darville, T. (2003) J. Biol. Chem. 278, 9496–9502
21. Lipinski, S., Till, A., Sina, C., Arlt, A., Grasberger, H., Schreiber, S., and
Rosenstiel, P. (2009) J. Cell Sci. 122, 3522–3530
22. Ojcius, D. M., Niedergang, F., Subtil, A., Hellio, R., and Dautry-Varsat,
A. (1996) Res. Immunol. 147, 175–188
23. Prantner, D., Darville, T., and Nagarajan, U. M. (2010) J. Immunol. 184,
2551–2560
24. Buss, C., Opitz, B., Hocke, A. C., Lippmann, J., van Laak, V., Hippenstiel,
S., Kru¨ll, M., Suttorp, N., and Eitel, J. (2010) J. Immunol. 184, 3072–3078
25. Shinohara, M., Adachi, Y., Mitsushita, J., Kuwabara, M., Nagasawa, A.,
Harada, S., Furuta, S., Zhang, Y., Seheli, K., Miyazaki, H., and Kamata, T.
(2010) J. Biol. Chem. 285, 4481–4488
26. Zhou, R., Tardivel, A., Thorens, B., Choi, I., and Tschopp, J. (2010) Nat.
Immunol. 11, 136–140
27. Papaiahgari, S., Kleeberger, S. R., Cho, H. Y., Kalvakolanu, D. V., and
Reddy, S. P. (2004) J. Biol. Chem. 279, 42302–42312
28. Cheng, G., Cao, Z., Xu, X., van Meir, E. G., and Lambeth, J. D. (2001)
Gene 269, 131–140
29. Takeya, R., Ueno, N., and Sumimoto, H. (2006)Methods Enzymol. 406,
456–468
30. Azenabor, A. A., Yang, S., Job, G., and Adedokun, O. O. (2005)Med.
Microbiol. Immunol. 194, 91–103
31. Ka¨lvegren, H., Bylin, H., Leanderson, P., Richter, A., Grenegård, M., and
Bengtsson, T. (2005) Thromb. Haemost. 94, 327–335
32. Welter-Stahl, L., Ojcius, D. M., Viala, J., Girardin, S., Liu, W., Delarbre,
C., Philpott, D., Kelly, K. A., and Darville, T. (2006) Cell. Microbiol. 8,
1047–1057
33. Opitz, B., Fo¨rster, S., Hocke, A. C., Maass, M., Schmeck, B., Hippenstiel,
S., Suttorp, N., and Kru¨ll, M. (2005) Circ. Res. 96, 319–326
34. Buchholz, K. R., and Stephens, R. S. (2008) Infect. Immun. 76,
3150–3155
35. Derbigny, W. A., Kerr, M. S., and Johnson, R. M. (2005) J. Immunol. 175,
6065–6075
36. Su, H., McClarty, G., Dong, F., Hatch, G. M., Pan, Z. K., and Zhong, G.
(2004) J. Biol. Chem. 279, 9409–9416
37. Verbeke, P., Welter-Stahl, L., Ying, S., Hansen, J., Ha¨cker, G., Darville,
T., and Ojcius, D. M. (2006) PLoS Pathog. 2, e45
38. Stephens, R. S. (2003) Trends Microbiol. 11, 44–51
39. Scidmore, M. A., and Hackstadt, T. (2001)Mol. Microbiol. 39,
1638–1650
40. McClarty, G. (1994) Trends Microbiol. 2, 157–164
NLRX1 Enhancement of ROS Production and Chlamydial Infection
DECEMBER 31, 2010•VOLUME 285•NUMBER 53 JOURNAL OF BIOLOGICAL CHEMISTRY 41645
 at U
niv of the Pacific on A
pril 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Rosenstiel and David M. Ojcius
Pettengill, Fraser Soares, Ivan Tattoli, Simone Lipinski, Stephen E. Girardin, Philip 
Ali A. Abdul-Sater, Najwane Saïd-Sadier, Verissa M. Lam, Bhavni Singh, Matthew A.
the Mitochondrial Nod-like Family Member NLRX1
Enhancement of Reactive Oxygen Species Production and Chlamydial Infection by
doi: 10.1074/jbc.M110.137885 originally published online October 19, 2010
2010, 285:41637-41645.J. Biol. Chem. 
  
 10.1074/jbc.M110.137885Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/285/53/41637.full.html#ref-list-1
This article cites 40 references, 15 of which can be accessed free at
 at U
niv of the Pacific on A
pril 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
